Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04985331 · ClinicalTrials.gov registry record · NA

Digital Therapeutic vs Psychoeducation for Management of Mild to Moderate Depression in Adolescents

A NA study of Depression, Teen, sponsored by Woebot Health.

Completed
Registry status
NA
Development phase
246
Enrollment target
1
Study location

NCT04985331 is a NA study of Depression, Teen that has completed, run by Woebot Health. The registered enrollment target is 246 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04985331, a NA study of Depression, Teen, has completed, sponsored by Woebot Health.

COMPLETED
Registry status
NA
Development phase
246 participants
Enrollment target
1
Study location

Study Summary

The purpose of the present randomized controlled study is to investigate if there is a difference in depression symptoms at 4-weeks among adolescents ages 16-17 years assigned to W-GenZD, a digital therapeutic, as compared to a psychoeducational control group.

Conditions Studied

Interventions

  • DEVICE W-GenZD

Study Locations (1)

California

  • Woebot Health - San Francisco

Trial Details

FieldValue
Enrollment Target 246 participants
Start Date 2021-08-02
Est. Completion 2022-01-04
Phase NA

Sponsor

Woebot Health

13 total trials

What the Registry Record Tells You About NCT04985331

The ClinicalTrials.gov registry entry for NCT04985331 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 246 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Woebot Health, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depression, Teen appearing as the primary indexed condition, and to 1 intervention - of which W-GenZD is the first listed.

NCT04985331 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04985331 about?

NCT04985331 is a clinical study titled "Digital Therapeutic vs Psychoeducation for Management of Mild to Moderate Depression in Adolescents". The purpose of the present randomized controlled study is to investigate if there is a difference in depression symptoms at 4-weeks among adolescents ages 16-17 years assigned to W-GenZD, a digital therapeutic, as compared to a psychoeducational control group.

What is the current status of trial NCT04985331?

This trial is currently completed. It is a NA study. The enrollment target is 246 participants. The study started on 2021-08-02. Estimated completion is 2022-01-04.

What conditions does trial NCT04985331 study?

This clinical trial studies the following conditions: Depression, Teen.

What interventions are being tested in trial NCT04985331?

The interventions under investigation include: W-GenZD (DEVICE).

Who is sponsoring clinical trial NCT04985331?

This trial is sponsored by Woebot Health, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04985331 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression, Teen

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.